Hcsf Management Has Raised Cherokee Del New (CHKE) Position By $550,680; Ghost Tree Capital Has Trimmed K2m Group Hldgs (KTWO) Holding

December 12, 2017 - By Hazel Jackson

Hcsf Management Llc increased Cherokee Inc Del New (CHKE) stake by 5.87% reported in 2017Q2 SEC filing. Hcsf Management Llc acquired 91,780 shares as Cherokee Inc Del New (CHKE)’s stock rose 8.60%. The Hcsf Management Llc holds 1.65 million shares with $11.50M value, up from 1.56M last quarter. Cherokee Inc Del New now has $29.30M valuation. The stock increased 7.69% or $0.15 during the last trading session, reaching $2.1. About 194,360 shares traded or 21.02% up from the average. Cherokee Inc. (NASDAQ:CHKE) has declined 29.62% since December 12, 2016 and is downtrending. It has underperformed by 46.32% the S&P500.

Ghost Tree Capital Llc decreased K2m Group Hldgs Inc (KTWO) stake by 47.37% reported in 2017Q2 SEC filing. Ghost Tree Capital Llc sold 135,000 shares as K2m Group Hldgs Inc (KTWO)’s stock rose 7.92%. The Ghost Tree Capital Llc holds 150,000 shares with $3.65M value, down from 285,000 last quarter. K2m Group Hldgs Inc now has $754.35M valuation. The stock decreased 0.40% or $0.07 during the last trading session, reaching $17.41. About 194,009 shares traded. K2M Group Holdings, Inc. (NASDAQ:KTWO) has risen 113.03% since December 12, 2016 and is uptrending. It has outperformed by 96.33% the S&P500.

Among 6 analysts covering Cherokee (NASDAQ:CHKE), 5 have Buy rating, 0 Sell and 1 Hold. Therefore 83% are positive. Cherokee had 13 analyst reports since August 4, 2015 according to SRatingsIntel. The firm has “Buy” rating by TH Capital given on Thursday, September 17. Roth Capital maintained Cherokee Inc. (NASDAQ:CHKE) rating on Sunday, August 20. Roth Capital has “Buy” rating and $10.0 target. The firm has “Buy” rating by Wunderlich given on Friday, September 9. The firm earned “Buy” rating on Tuesday, August 4 by Wunderlich. On Wednesday, September 2 the stock rating was maintained by Brean Capital with “Buy”. The company was downgraded on Friday, March 10 by B. Riley & Co. The stock of Cherokee Inc. (NASDAQ:CHKE) has “Buy” rating given on Thursday, September 17 by Roth Capital. Wunderlich maintained the stock with “Buy” rating in Friday, September 11 report. The rating was maintained by Roth Capital with “Buy” on Tuesday, October 20. As per Thursday, September 28, the company rating was maintained by Roth Capital.

Investors sentiment decreased to 0.68 in Q2 2017. Its down 0.54, from 1.22 in 2017Q1. It is negative, as 5 investors sold CHKE shares while 13 reduced holdings. 8 funds opened positions while 14 raised stakes. 9.75 million shares or 0.73% more from 9.68 million shares in 2017Q1 were reported. Dimensional Fund LP reported 353,238 shares stake. Trellus Lc owns 75,000 shares for 0.77% of their portfolio. 485 are owned by Fifth Third Bank. Renaissance Tech Ltd owns 542,449 shares. Deutsche Commercial Bank Ag invested 0% of its portfolio in Cherokee Inc. (NASDAQ:CHKE). Northpointe Lc accumulated 948,873 shares or 0.69% of the stock. Park Circle Communications reported 332,531 shares. Menta Limited Liability Corp has invested 0.01% of its portfolio in Cherokee Inc. (NASDAQ:CHKE). Penn Company owns 516,718 shares. Blackrock stated it has 280,542 shares. Northern Trust Corporation holds 0% of its portfolio in Cherokee Inc. (NASDAQ:CHKE) for 30,839 shares. 1492 Capital Mngmt Ltd Llc has 20,432 shares for 0.13% of their portfolio. Farmers And Merchants holds 245 shares or 0% of its portfolio. Bank & Trust Of America Corporation De holds 0% or 300 shares in its portfolio. Hcsf Mngmt Lc reported 1.65M shares stake.

Ghost Tree Capital Llc increased Genmark Diagnostics Inc (NASDAQ:GNMK) stake by 175,000 shares to 825,000 valued at $9.76M in 2017Q2. It also upped Portola Pharmaceuticals Inc (Put) (NASDAQ:PTLA) stake by 200,000 shares and now owns 400,000 shares. Acorda Therapeutics Inc (NASDAQ:ACOR) was raised too.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.



Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: